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ON THE COVER: Dr. Vanessa Rizzo, a resident at the Cornell University Hospital for Animals, has 
spent a lifetime surrounded by cancer. Today, she’s helping others calm the chaos that cancer can 
cause. Story on page 3.
Today, pioneering faculty work at the intersection of disciplines to study cancer from biochemical, genetic, epigenetic, and cellular perspectives. At the College, innovative thinking is leading to the development of 
new therapeutic targets, from the discovery of drugs designed 
to selectively silence epigenetically modified cells, to those 
designed to modify the metastasis machinery, and others that 
target the cancer stem cells that are the source of newly trans-
formed cells.
Targeted therapies that attack the cellular process essential 
to a specific cancer hold the promise of markedly improving 
treatment effectiveness by selectively acting on cancer cells 
while leaving healthy cells and tissues relatively untouched, 
compared to traditional chemotherapy. These therapies, used 
in combination with traditional approaches of chemotherapy, 
radiation, and surgery, promise significantly improved survival 
rates and decreased treatment failures. Personalized medicine 
extends this approach even further with treatment plans that 
respond at an individual level, by considering the animal’s and 
the cancer’s genetic composition.
Of course it is also important to highlight the challenges as-
sociated with cancer research and to acknowledge the complex-
ity, diversity, and tenacity of biological processes underlying tu-
mor formation (neoplasia). Cancer cannot be traced to a single 
gene or mutation or toxic insult—its complexity mirrors that of 
In this issue of ‘Scopes we highlight progress being 
made by faculty members in understanding cancer. 
Cancer research, one of the four research focuses 
identified in the College’s strategic plan, offers 
tremendous translational opportunities to improve 
animal and human health, as we begin to better 
understand the complex cellular alterations that 
converge to result in unrestrained cell growth. The 
programs highlighted here are a sample of research 
pursued in the Sprecher Cancer Institute and the Cor-
nell Comparative Cancer Center, in which a unique 
comparative approach is taken to advancing our 
understanding of the genetic basis of the formation 
of tumors. While arising from many distinct molecu-
lar alterations, at its core cancer shares remarkable 
similarities in mammals, and the high incidence of 
specific tumors in certain animal breeds presents 
both a challenge and an opportunity as we begin to 
unravel cancer genetics.
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the cell itself. No single drug inhibiting one step within a network of converg-
ing molecular processes will be sufficient to “cure cancer,” but as our under-
standing and analysis of individual tumors improve, we will be increasingly 
effective at treating a range of these devastating diseases.
 While there are limits to the aggressiveness with which we treat cancer in 
animals, it is clear that many of our current treatment options are combina-
tions of drugs that kill all dividing cells, but fail to eliminate transformed cells, 
which regrow all too rapidly. Real cures will entail more specific treatments, 
and a just-over-the-horizon range of immunotherapeutics, targeted kinase in-
hibitors, and gene silencers will considerably expand the oncologist’s options 
in the coming years. Moreover, information that emerges from spontaneous 
tumors in animals provides an outstanding opportunity to understand the 
complex genetics underlying tumor development in people, where the ge-
netic diversity of individuals is a barrier to gene discovery. Cornell’s priori-
tization and investments in cancer research recognize these opportunities to 
transform the treatment of neoplasia in animals and people.
 The answers will not come easily, but the possibility of a future where 
cancer is increasingly controlled—as the articles in this issue of ’Scopes dem-
onstrate—surely exists.
Cordially,
Michael I. Kotlikoff, VMD, PhD
Austin O. Hooey
Dean of Veterinary Medicine
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With as much conviction as one can muster, Dr. Vanessa Rizzo be-lieves that even when the death grip of cancer has taken hold, there can be value to taking steps that will postpone the inevitable.
To do this with as little pain and as much quality as possible, people and pets 
need skilled oncologists, and although Dr. Rizzo’s path to veterinary school 
was not necessarily straight, once enrolled, her course to helping people deny 
cancer’s devastation has been scalpel-sharp. 
A second-year oncology resident at the Cornell University Hospital for 
Animals, Dr. Rizzo is both a teacher and a student. Sharing her knowledge 
with veterinary students and those completing one-year internships, she 
finds satisfaction in preparing more minds to tackle the amazing and con-
founding disease known as cancer. As a student herself, she says that Cor-
nell’s residency program is one of the best in the nation. 
“I feel so grateful to have been accepted into this program,” said Dr. Rizzo. 
“And if I’m good at my job it’s only because I have an amazingly supportive 
team helping me. Everything I do for my patients and my clients is done after 
consulting with those in the oncology service and sometimes after consulta-
tions with doctors and staff from other services as many of our patients don’t 
just have cancer:  they have other diagnoses that need to be addressed so that 
we can help them maintain a good quality of life.”
The residency program at Cornell is the final three years of a 12-year quest 
to become board-certified in a specific area of medicine. The additional train-
ing provides residents with a high level of proficiency in the clinical disci-
pline. Each program allows the resident to meet the post-graduate education 
requirements of the national governing board related to that discipline as well 
as to gain experience in professional veterinary medical education and in 
teaching. In addition to the oncology residency, the College offers more than a 
dozen residency programs and has approximately 60 residents enrolled every 
year.
Cancer has special significance for Dr. Rizzo as she grew up surrounded 
by the disease: her grandmother died of cancer before she was born; her great 
aunt survived several kinds of cancer; she watched a school friend deal with 
cancer in the eighth grade; a family friend died of lung cancer when she was 
16; her mother is a breast cancer survivor; and her brother-in-law survived 
brain cancer. 
“As a child, I had a rudimentary 
understanding of cancer as a dis-
ease,” said Dr. Rizzo. “I knew that 
sometimes you died and sometimes 
you didn’t. My first cancer case as 
a veterinary student opened my 
eyes. I started reading about the bi-
ology and pathophysiology of can-
cer and was hooked. Although you 
can simplify the condition by saying 
that cancer develops when cells go 
haywire, its a multitude of different 
diseases, each with its own microen-
vironment and behavior.”
These behaviors can make life 
difficult. As a specialist, Dr. Rizzo 
hopes to make horrible days a little 
better by being as informative and 
honest as possible with her cli-
ents. Long-term, though, Dr. Rizzo 
dreams of changing the prospects 
for those targeted by cancer through 
life-changing comparative clinical 
research initiatives.
“When animals naturally de-
velop cancer, the knowledge that we 
gain from treating these animals has 
enormous potential to help develop 
new treatments for children,” said 
Dr. Rizzo. “Dogs and children share 
many of the same diseases. We need 
to do a better job of sharing data be-
tween the species. Completing this 
residency will help me do that.” 
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From grade school to
post graduate school
| T E A C H I N G
From the minutia of micro-scopic cells to the mind-expanding sessions that illustrated unconsidered 
career options, Cornell’s Leadership 
Program for Veterinary Students 
was life-changing for Jane Park, a 
member of the College’s veterinary 
class of 2015. With just a handful of 
research training programs tailored 
for aspiring veterinarians in exis-
tence, competition is intense. Cor-
nell selects fewer than 30 students 
each year from an international pool 
of 90 applicants.
“Cornell’s program provides 
students with learning experiences 
that clarify and reinforce their com-
mitment to careers in science,” said 
Dr. John Parker, program director 
and associate professor of virology. 
“The program is distinguished by a 
tradition of excellence that spans 24 
years. During this time, more than 
550 alumni have participated. These 
individuals have come from 62 vet-
erinary colleges in all parts of the 
world and many, as we had hoped, 
have become scientific leaders with-
in the veterinary profession.”
Park set her sights on Cornell’s 
program because she knew that she 
would get phenomenal training in 
research techniques as well as tips 
for preparing for graduate training. 
Park expects to earn a doctoral de-
gree after completing Cornell’s vet-
erinary program and said she went 
into the experience with high hopes. 
“Even my expectations didn’t 
do the program justice,” said Park. 
“I walked away with many skills I 
could use to succeed in a multitude 
of possible career paths.”
From Long Island, Park came to 
Cornell’s veterinary program after 
spending time at the Brookhaven 
National Laboratory, also in Long 
Island, where she worked in a radia-
tion and oncology laboratory along-
side physicists, veterinarians, and 
human medical doctors to develop a 
unique microbeam radiation thera-
py to more accurately target tumors. 
Through this introduction to both 
cancer research and the power of 
multiple perspectives, Park gained 
a deeper understanding of the One 
Health initiative while at Brookhav-
en. 
“Research bridges the various 
medicines,” said Park. “I saw that at 
Brookhaven and was reminded of it 
again during my Leadership expe-
rience at Cornell. Although we are 
often behind the scenes, veterinar-
ians have critical knowledge when 
it comes to solving public health is-
sues like West Nile virus and other 
zoonotic diseases. Of course society 
needs veterinarians who offer gen-
eral practice services. But we also 
need veterinarians who are leaders 
in government, academia, industry, 
and research.” 
In just 10 weeks, Cornell’s Lead-
ership Program for Veterinary Stu-
dents presents career opportunities 
in all of these industries and covers 
issues that range from ethics and 
creativity in science to designing ef-
fective research programs and pick-
ing appropriate professional men-
tors. Participants meet with repre-
sentatives of organizations like the 
National Institutes of Health and the 
Walter Reed Army Institute of Re-
search and Naval Medical Research 
Center and complete a variety of 
workshops and modules in Ithaca 
and Washington D.C. 
Research, though, is the major 
focus of Cornell’s program. Scholars 
pursue individual research projects 
under the guidance of Cornell fac-
ulty members who are all highly 
successful scientists and experi-
enced mentors. The University’s 
world-class research facilities and 
unsurpassed intellectual environ-
ment support the scholars’ research 
investigations. 
Park worked in Dr. Scott Coon-
rod’s laboratory, characterizing an 
enzyme that may be implicated in 
the presence of squamous cell car-
cinoma. Although she wasn’t able 
to statistically confirm any patterns, 
Park said she found trends that sug-
gest there may be a relationship be-
tween the presence of the enzyme 
known as PADI2 and squamous cell 
carcinoma, one of the more common 
forms of skin cancer. 
“More than the end results, 
though, I learned new techniques 
and perfected skills that I can use at 
the bench for the rest of my career,” 
said Park. “The Leadership Program 
is multi-faceted and life-changing.”
to bridge health needs
Developing veterinary scientists
to bridge health needs
Developing veterinary scientists
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behind the curtains
translational oncology research 
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Years of research have paved the path to the many successes we 
see in veterinary exam rooms today. Researchers at Cornell’s 
College of Veterinary Medicine are laying the bricks for healthy 
lives, across many specialties, including oncology, where better 
cancer treatment and prevention strategies are direct outcomes 
of translational research conducted at Cornell. We hope you 
enjoy the following examples of just some of the oncology 
research happening at the College. 
translational oncology research 
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Uncovering cancer’s origins, unlocking earlier 
detection
Meet...Dr. Alexander Nikitin 
The most common and aggressive type of ovarian cancer, ovarian carcinoma, leaves a 
dark trail. Science has learned too little and most women learn too late that they have 
it to effectively treat the deadly disease. Recently, College scientists have found ovar-
ian carcinoma’s first proven origin cells and uncovered clues for finding similar sourc-
es of other cancers. The study opens paths for new screening methods to detect cancer 
earlier and increase treatment chances in the ovaries and other parts of the body.
Most organs, including the ovaries, have stem-cells, which help healing and de-
velopment, but many cancers start when such cells go astray. Using a novel cell lo-
cation technique never before used in ovaries, the study uncovered a nest, known 
as a niche, of particularly cancer-prone stem cells located in the ovaries where dif-
ferent tissue types meet. It provides the most direct proof yet that vulnerable 
stem cells can nest near such tissue junctions, which occur throughout the body.
“Poor understanding of ovarian cancer’s development has posed the biggest road-
block to helping its victims,” said Dr. Alexander Nikitin, pathology professor at the 
College and leader of the University’s Stem Cell Program. “We have found what 
is very likely to be the source of cells from which ovarian carcinoma arises, as well 
as the strongest suggestion yet that cancer-prone stem cells can nest in tissue junc-
tions. This could spur new discoveries of cancer-prone stem cell niches throughout 
the body, revealing new ways to screen for and diagnose several different cancers.”
Stopping cancer’s spread
Meet...Dr. Richard Cerione
Cancer cells must prepare for travel before invading 
new tissues, but the results of research at the Col-
lege have found a possible way to stop these cells 
from ever hitting the road. The lab of Dr. Richard 
Cerione, Goldwin Smith Professor of Pharmacology 
and Chemical Biology at Cornell’s College of Veter-
inary Medicine, identified two key proteins needed 
to get cells moving and uncovered a pathway that 
treatments could block to immobilize cancer cells.
Metastasis relies on cell migration, the abil-
ity of some cells to move. Observing breast can-
cer cells in culture, Dr. Cerione’s lab found that 
cancerous cells become hyperactive invasion ve-
hicles by using a protein called tissue transglu-
taminase (tTG) together with other proteins like 
wheels, poking them through the surface to form 
a leading edge that pulls the cell forward. To get 
those wheels to the leading edge, they need an-
other protein to roll them there—a chaperone 
protein called heat-shock-protein-70 (Hsp70).
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Bridging the divide
Meet...Dr. Nedra Holmes
Some veterinarians dedicate their lives to today’s pa-
tients; some researchers work toward tomorrow’s dis-
coveries. Other veterinary scientists bridge the roles 
by doing both, working on translational research de-
signed to equip clinics with new tools to help patients. 
Dr. Nedra Holmes, a Cornell Clinical Fellow, is 
building such a bridge. Combining perspectives 
from her imaging residency at Cornell Univer-
sity Hospital for Animals (CUHA) with compre-
hensive research training in the lab of Dr. Robert 
Weiss, professor of biomedical sciences, she is 
using molecular imaging to investigate new di-
agnostics and therapy targets for lung cancer. 
More people die from lung cancer than from any 
other cancer type, according to the Centers for Dis-
ease Control and Prevention, but early intervention 
dramatically increases the chances of survival. Collab-
orating with researchers and clinicians on Cornell’s 
Ithaca campus and the Weill Cornell Medical College 
Citigroup Biomedical Imaging Center in New York 
behind the curtains
City, Dr. Holmes combines two imaging techniques 
to study metabolic patterns in tumors as a means of 
diagnosis and to better understand how they form. 
Computed tomography (CT) uses x-rays to pro-
duce images more detailed than radiographs, 
while positron emission tomography (PET) al-
lows non-invasive in-body imaging of molecu-
lar processes. By using both techniques on tumors 
to reveal their metabolic patterns, Dr. Holmes is 
exploring the differences in how benign and ma-
lignant tumors burn energy and the role played 
by Sirtuin 5, a protein important in metabolism 
that gets overexpressed in many human cancers.
“We think this protein may be responsible for a 
lot of the metabolic hyperactivity that drives can-
cer cells’ growth,” said Dr. Holmes. “Molecular im-
aging techniques will help reveal how this protein 
works in healthy and unhealthy cells. Our hope is 
that, by inhibiting this protein in cancerous cells, 
we may be able to slow or stop tumor growth.”
“If we can better understand how Hsp70 in-
fluences tTG, we can find ways to modulate that 
interaction to immobilize cancer cells and keep 
them from becoming invasive,” said Dr. Cerione. 
Meanwhile his lab discovered another more in-
sidious way cancer propagates: by sending sur-
prise packages that turn normal cells cancerous. 
Dr. Cerione’s lab demonstrated the parcels’ cancer-
causing powers, described how they are made, and 
revealed a way to jam production. Treatments that 
follow suit could slow tumor growth and metastasis.
Remote recruiting through an inter-cellular mail 
system allows cancer cells to grow their ranks with-
out having to move. While most cells communicate 
through substances that stimulate growth and hor-
mones, cancer cells and stem cells use microvesicles, 
which are stuffed with unconventional cargo that 
boosts the survival and growth rates of recipient cells 
and can completely change their form and function.
“Even if we immobilize cancer cells, as long 
as they can make these microvesicles they can 
continue spreading cancer,” said Dr. Cerione. 
“Treatments targeting the microvesicle pro-
duction pathway we’ve outlined could have 
a real impact on slowing cancer progression.”
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behind the curtains
Supporting cancer breakthroughs with novel research and 
intense training programs
In 2008, the Wilpon Family Foundation established a research professorship 
in cancer biology at the Baker Institute, a position held by Dr. Scott Coonrod 
since its inception. Fueled by Judy Wilpon’s long-standing interest in 
animal health and her personal commitment to advancing the diagnosis, 
treatment, and prevention of cancer, the gift sets the stage to permanently 
endow the position. The Baker Institute is committed to raising additional 
funds up to $1 million to match the generosity of the Wilpon family. To date, 
more than $600,000 has been raised.
The Wilpons’ gift also provided the Sprecher Institute for Comparative 
Cancer Research with challenge funds that will match dollar for dollar 
(up to $1 million) gifts to permanently endow and name two oncology 
residencies, like the position that Dr. Vanessa Rizzo (story on page 3) holds.
For more information on how to help support Dr. Scott Coonrod’s 
groundbreaking work (story on page 11) or positions like Dr. Rizzo’s, please 





There are hundreds of kinds of 
cancers, and although no two 
are exactly alike, at the core, 
they all have one weapon in 
common: fruitful cells that mul-
tiply out of control and are des-
tined to overtake healthy cells. 
Dr. Scott Coonrod and his team 
at the College’s Baker Institute 
for Animal Health are explor-
ing new compounds that can 
shut down one of the main tools 
cancer cells use to turn on genes 
that cause rapid cell growth. 
His group is among the pio-
neers using cancer epigenetics 
to make discoveries like these. A 
relatively new field, cancer epi-
genetics investigates chemical 
changes in our genetic material 
and the proteins that regulate 
when and how a gene is turned 
on. Cancer epigenetics research-
ers have found that in tumor-
prone cells, certain modifications 
to small clusters of proteins in 
the cell’s nucleosome appear to 
be stuck in the “on” position for 
genes involved in cell prolifera-
tion, leading to tumor growth 
and eventually metastasis. 
“One of our priorities is to 
find new drugs that block the 
activity of the enzymes that 
lead to these modifications and 
then test whether these new 
‘epigenetic inhibitor’ drugs can 
block cancer growth,” Dr. Coon-
rod, associate professor, said. 
Toward that goal, the Coon-
rod team has set its sights on an 
epigenetic enzyme nicknamed 
PADI2. The team’s research con-
firmed the expression of this en-
zyme in the mammary gland and 
found that production of this 
enzyme is regulated by estro-
gen. They also found that PADI2 
works in concert with estrogen 
to turn on proliferation genes by 
placing a new chemical, citrul-
line, at genes targeted by PADI2 
and estrogen. Dr. Coonrod’s 
team also made the very recent 
discovery that, in addition to es-
trogen receptor-positive breast 
cancer (more than 75 percent of 
all breast cancers), PADI2 activ-
ity appears to be linked to other 
forms of breast cancer, includ-
ing HER2-positive breast cancer, 
which accounts for about one of 
every five breast cancer cases.
“We know that following re-
moval of the primary tumor, 
many women take drugs such 
as Tamoxifen or Trastuzumab to 
prevent tumor recurrence,” said 
Dr. Coonrod. “However, most 
women eventually become re-
sistant to these drugs. Therefore, 
there is a critical need to develop 
new drugs that can block these 
cancer pathways. We believe that 
PADI2 may represent just such a 
drug, and we are currently try-
ing to move this drug through 
the cancer drug development 
pipeline so that the inhibitors 
can be used to treat both human 
and companion animal cancers 
in the not-too-distant future.”
A numbers game — new drug shows 
promise in blocking tumor growth 
Meet...Dr. Scott Coonrod
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Cancer scientists talk life–and shop–
with cancer patients
Program connects researchers with those their work 
benefits
Conceived by Bob Riter, di-
rector of the Cancer Resource 
Center of the Finger Lakes, 
the program connects doc-
toral and post-doctoral stu-
dents with cancer patients, 
survivors, caregivers, and family. 
“Many of Cornell’s scientists-
in-training studying cancer do 
not have an opportunity to get 
out of their laboratories and 
meet individuals directly affect-
ed by the disease that they are 
researching,” said Riter. “Peo-
ple with cancer want scientists 
involved in cancer research to 
understand that they are more 
than cells or molecular path-
ways. They are people first.”
Toward this end, eight 
people engaged in cancer re-
search at Cornell have been 
attending various support 
group meetings sponsored by 
the Cancer Resource Center. 
“The need for our research 
programs to succeed and trans-
late at some point into a treat-
ment is so clear when you listen 
to stories about cancer patients’ 
lives,” said Dr. Joanna Mlec-
zko, a post-doctoral student in 
Dr. Robert Weiss’ lab at Cor-
nell who is looking for potential 
drugs to treat cancer. “As scien-
tists, we are working on very 
intricate pieces of the puzzle. It 
is easy to lose sight of the big 
picture. The opportunity to re-
ally see the impact and the anx-
ieties and the challenges that 
cancer patients face with treat-
ments and the related side ef-
fects is powerful motivation.” 
In difficult situations, talking of-
ten helps. It works best, of course, 
when there is someone listening. 
A new initiative connects Cor-
nell scientists studying cancer 
with people living with cancer. 
As the program has unfolded, 
illustrations of the real-time, real-
life impact of cancer and cancer 
research have developed shared 
understandings that have rein-
vigorated the passion Cornell 
scientists bring to the bench and 
have generated newfound hope 
for those waiting for answers. 
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Equally powerful will be the 
opportunity for cancer patients 
and survivors to learn about new 
directions in cancer research. 
“Members of our sup-
port groups are eager to learn 
about the advances in cancer 
research,” said Riter. “Cancer 
is frustratingly complex, but 
thanks to basic science research, 
cancer treatments are becoming 
more effective and less toxic.”
Currently the investigators are 
attending support group meet-
ings. They listen and share infor-
mation about the pathogenesis 
of the disease, explaining, for 
instance, what tumor suppres-
sion is and how damaged DNA 
leads to tumors. In addition, 
planning for a yearly research 
symposium is underway. The 
event will provide a forum for 
scientists to explain their work 
in ways that will generate public 
understanding and support—a 
When some cancers strike, che-
motherapy seems to be omnipo-
tent. Other times, the deadly cells 
render the therapy powerless. 
Understanding the molecular 
and genetic mechanisms at the 
root of these two scenarios has 
the potential to transform our 
understanding of cancer biolo-
gy and yield important insights 
for how to treat various cancers. 
Dr. Robert Weiss believes that 
one of the keys to understand-
ing the different driving forces 
in cancers that respond to che-
motherapy and those that don’t 
may lie in the ability of cells to 
mount an effective DNA dam-
age response (DDR). In studies 
funded by the NY State Stem 
Cell Program (NYSTEM), he 
skill increasingly necessary for 
scientists who rely on external 
funding to sustain their work.
“Overall, the program pro-
vides an opportunity for scien-
tists to explain their work in lay 
language, expose them to the 
concerns of cancer patients and 
survivors, and educate those 
living with cancer about new di-
rections in cancer research,” said 
Riter. “It’s a mutually beneficial 
arrangement with meaning-
ful outcomes for all involved.” 
and his team are investigat-
ing how this critical regulatory 
process operates in stem cells, 
theorizing that the findings will 
have implications for the pre-
vention and treatment of can-
cers originating from stem cells.
“We have focused our work 
on testicular germ cells for sev-
eral reasons,” said Dr. Weiss, 
associate professor of molecu-
lar genetics. “They share many 
biological properties with the 
stem cells being developed for 
therapeutic applications. They 
are amenable to experimental 
analysis. And, they are the pre-
cursors to testicular germ cell 
tumors (TGCTs), the most com-
mon cancers of young men and 
a cancer type that is remark-
ably sensitive to chemotherapy.”
The team is building on cur-
rent evidence that suggests that 
the DDR operates differently in 
testicular germ cells and other 
stem cells than in other tissues. 
“We hypothesize that these 
unique characteristics originate 
from the stem cell-like prop-
erties of the germ cells from 
which testicular germ cell tu-
mors originate and that these 
properties influence how these 
cancers develop and respond 
to therapies,” said Dr. Weiss. 
“If we can understand why and 
how chemotherapy is success-
ful in some cases, we can work 
to replicate the situation in cases 
where it has not been successful.
Bob Riter (right) pictured with (from left) Sachi Horibata, Jack Stupinski, Joanna Mleczko, and 
Claire Anderson.
Picking up Bo for the first time the day before a charity auction she was chairing back in 2005, Kristin Sel-vala had meant to keep the yellow 
lab pup for just one night. He was 
supposed to be the top prize, but the 
Selvala family quickly fell in love. 
Finding another puppy to auction at 
the last minute, they adopted Bo for 
good. He grew into a happy adult 
who loved to eat and run. When a 
little black lab brother joined the 
house they became fast friends.
“Bo and his brother played so 
much you’d think they’d never run 
out of energy,” said Selvala. “But 
two years later Bo started seem-
ing tired. He lost his appetite. One 
day he was so ill he crept under 
the bushes by the house and stayed 
there all day. It was so sad to see him 
in that condition. When our vet did 
an ultrasound and saw his abdomen 
had swollen, he said to get to a spe-
cialist quickly.”
The Selvalas brought Bo to Cornell University Veteri-
nary Specialists (CUVS), Cornell’s emergency and special-
ty care satellite hospital in Stamford, Conn. Tests revealed 
devastating news: Bo had hepatic (liver) lymphoma, a 
blood cancer from which few dogs recover. 
“We were on a very tight budget, but the thought of 
losing him was overwhelming to us,” said Selvala. “We 
were willing to do whatever it took to save him.”
Close to death, Bo began chemotherapy treatment un-
der the care of CUVS oncologist Dr. Gerry Post. 
“Bo was incredibly sick,” said Dr. Post. “Cancer 
throughout his liver and spleen was putting pressure on 
his stomach and making him too nauseous to eat. The 
prognosis for his type of lymphoma is very poor when 
treated with standard chemotherapy. So we decided to try 
a different method.”
Years ago Dr. Post had published research showing 
that different types of lymphoma respond differently to 
treatments. Using a new treatment protocol that Dr. Post’s 
research had shown to be more effective for Bo’s type, 
CUVS staff helped Bo beat lymphoma and turn his health 
around. Through the combined effort of critical care, inter-
nal medicine, and oncology, Bo regained his appetite and 
got back on his feet. After a year of treatment, the cancer 
regressed. Now Bo has lived more than a year cancer-free, 
with fully renewed appetite, energy, and love of play. 
“Our family saw Bo come back to life,” said Selvala. 
“The CUVS staff members are truly amazing. They’re like 
an extended family for him. Bo never once hesitated to 
run through the door and say hello. It’s a fantastic place; I 
recommend CUVS to all my friends who need emergency 
or specialty care. They supported him and me holistically; 
they’re so kind and loving, and I truly believe that made a 
big difference in bringing Bo back.”
Boback
bringing
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From the brink of death 
in cancer’s throes to a 
triumphant return to health 
and family, Bo Selvala beat 
terrible odds surrounded by 
luck and love. 
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She escaped that fate when she was bought by Susan 
Wagner, president of Equine Advocates Rescue and Sanc-
tuary, embarking on a new life at the group’s equine sanc-
tuary in Chatham, N.Y. 
“At first Mariclare was very difficult,” said Wagner. 
“She hated being handled. She was afraid of everything 
and everyone.”
But in 2007, Wagner got close enough to notice some-
thing wrong with her left eye. Her local veterinarian sus-
pected squamous cell carcinoma (SCC), a kind of malig-
nant tumor common in Belgians. Wagner began treating 
Mariclare at home with mitomycin, an anti-tumor oint-
ment. At first the growth shrank, but later started rapidly 
expanding. So Wagner drove the struggling 1600-lb horse 
to the Cornell University Hospital for Animals for surgi-
cal treatment. 
“She was terrified and her left eye looked dreadful,” 
said Dr. Nita Irby, large-animal ophthalmologist. “We 
found two large masses so extensive they couldn’t be re-
moved without losing the eye.”
Mariclare’s situation darkened further when Dr. Irby 
found more suspicious areas in her right eye. One raised 
cauliflower-like growth looked particularly like another 
SCC tumor. With all cards stacked against Mariclare’s 
sight, Dr. Irby’s team came up with a plan to remove her 
left eye after using a mask to adapt her to loss of vision 
on that side. Meanwhile, they would save her right eye 
right away through surgery and strontium-90 radiation 
therapy, using a radioactive probe to apply large doses of 
radiation. 
“Radiation requires general anesthesia, a risky proce-
dure in very large animals like Mariclare,” said Dr. Irby. 
“We tried to choreograph everything to minimize the 
time she’d be under.”
After careful anesthesia, a thorough exam revealed 
another tumor in her right eye. They conducted a CT 
(computed tomography) scan to confirm that no tumors 
were invading the bone or the lymph nodes in her head. 
Next they performed specialized surgeries to remove the 
right eye’s tumors. Biopsies confirmed all the tumors 
were SCC. 
But radiation had to wait until the surgery on the left 
eye because Mariclare’s blood pressure began dropping. 
Awakened for safety’s sake, she went home to recover. 
There Wagner helped her acclimate to being blind on the 
left side with the impending loss of that eye by maintain-
ing in place an eye mask Dr. Irby prescribed. She soon 
returned to Cornell, where the team successfully removed 
her left eye and radiated the right. 
Rechecking Mariclare’s eye every six months, Dr. Irby 
found, removed, and irradiated a new small mass in 2010. 
Today, five and one half years after the journey began, 
Mariclare is cancer-free, able to see, and more at peace 
with people. 
“I think the world of Dr. Irby,” said Wagner. “She did 
what was right, what she felt Mariclare needed, and it 
worked. Since meeting her, Mariclare has changed. She 
approaches me in the field. When we pull a truck up to 
bring her for a checkup she gets right on. It’s a total turn-
around.”
When cancer first emerged to threaten her sight, Mariclare didn’t like people. 
The huge Belgian horse spent her first 12 years in an abusive situation, 
severely confined and destined for slaughter. 
A| S E R V I C E
bandoned in the backyard barn of a 
vacant house, Bandit and his brother 
faced a difficult first few weeks of life. 
But their dimming horizons bright-
ened when a friend of Pam Zygmunt, 
a mail-handler in Utica, N.Y., discov-
ered the tiny orange kittens in 2002. 
Upon seeing the pair, Zygmunt fell in 
love and took them in. 
When he first arrived at his new 
home, Bandit’s body was battling a 
severe upper respiratory infection. 
He lost an eye to the disease, but 
with veterinary care and determined 
dedication Zygmunt was able to 
nurse him back to health. Bandit and 
his brother acclimated well to their 
new home, a frequent refuge for res-
cued pets. Three happy years passed 
before Zygmunt noticed something 
wrong with Bandit’s ear. 
“Bandit thinks he’s the king of 
the house. He’s a very laid back cat 
and nothing seems to bother him,” 
said Zygmunt. “He and his brother 
like to tussle, so I figured it was just 
an injury. But when I took him to a 
nearby vet, we found it was cancer. 
They had to remove half his ear.” 
That staved off the cancer for 
a while, but it soon returned. This 
time Bandit lost the rest of his ex-
ternal ear. The best next step, Zyg-
munt’s vet told her, was seeing the 
cancer specialists at Cornell Univer-
sity Hospital for Animals. 
There, under the guidance of Dr. 
Margaret McEntee ’86, professor 
and section chief of oncology, the 
oncology team made a plan to take 
Bandit’s battle to the next level.
triumph with time for toast
Bandit’s battle
’ S C O P E S  M A G A Z I N E  J U L Y  2 0 1 3  | 19
“We ran several tests and ana-
lyzed the area where his ear had suf-
fered from recurrent fibrosarcoma,” 
said Dr. McEntee. “Given the results 
and his history, we determined Ban-
dit’s best option was definitive ra-
diation therapy followed by another 
deeper surgery to remove more in-
ternal parts of the ear. He had to stay 
with us in the clinic for his month-
long course of radiation.”
Being away from Bandit was 
tough for Zygmunt, who lived and 
worked two hours too far from 
where he’d get his life-saving care.
“I cried when I first dropped 
him off for the month,” Zygmunt 
recalled. “A lot of people have two-
legged children. I have four-legged 
children. My pets are my life and I 
had to leave him. But every single 
night a student called me and let me 
know what was going on. They gave 
him blankets, toys, and love. He was 
spoiled rotten down there. They 
were excellent, wonderful to him, I 
couldn’t have asked for a better ex-
perience.”
This fall Bandit and Zygmunt 
will celebrate his fifth year of liv-
ing without cancer. He’s now a one-
eyed, one-eared, cancer-free cat and 
doesn’t mind a bit.
“I’m so happy to have him back, 
and he’s happy as ever,” said Zyg-
munt. “He can still hear so well 
that when he’s lounging in the liv-
ing room and the toaster pops from 
across the house he runs to get a 
bite.”
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Dr. Christian Gries ’63 believes 
that we are here to take care of this 
earth and each other. Of course 
there are many ways to fulfill 
this opportunity, and Dr. Gries 
is always on the look-out for a 
creative approach to accomplish 
this higher purpose.
When he had the chance to support both a “well-de-
serving organization” and pay tribute to his classmates 
and their time as Cornell veterinary students, Dr. Gries was 
quick to say yes to a gift to the College’s Annual Fund in 
honor of his 50th Reunion.
 “I hope that the gift will help the College set someone 
on the path to as good a life as I have had and am having,” 
said Dr. Gries, who was in the last graduating class that 
attended Cornell tuition-free. “My Cornell degrees [DVM 
and PhD] have provided me and my family with a very 
fruitful life. It feels good to give something back, especially 
knowing that it will be put to advantageous use.”
 The College of Veterinary Medicine’s Annual Fund is 
the best way for friends and alumni to help keep the Uni-
versity’s founding vision alive. These gifts enable today’s 
leaders to meet the greatest needs of the College and to 
seize important and often time-sensitive opportunities that 
may be as mind-expanding as additions to the collection 
in the Flower-Sprecher Veterinary Library or as life-giving 
as new equipment in the Cornell University Hospital for 
Animals.
 “Gifts to the Annual Fund are powerful in these chal-
lenging economic times,” said Dr. Michael I. Kotlikoff, Aus-
tin O. Hooey Dean of the College of Veterinary Medicine. 
“As it becomes increasingly difficult to rely on traditional 
funding sources, the power of gifts to the Annual Fund—
those that provide much needed flexibility and allow the 
College to take advantage of strategic opportunities—are 
particularly meaningful. Dr. Gries’ gift and others like it 
will allow us to continue to improve the Cornell experi-
ence.”
 After graduating at the head of his veterinary class and 
earning the Borden Scholarship Award, Dr. Gries imme-
diately pursued a doctoral degree in pathology, complet-
ing the Cornell program in 1966. With 12 years of college 
education behind him, he decided to get his “hands dirty,” 
working in Catskill, N.Y., for four years in a mixed animal 
practice where he treated species that ranged from kittens 
to camels. Following that, he shifted his focus, returning 
to Cornell for seven years to work in the College’s diag-
nostic laboratory. Ultimately, he accepted a position as a 
board certified pathologist with Eli Lilly and Company in 
Indiana, where he worked for nearly 25 years. In retirement 
since 2000, Dr. Gries said he is busier than ever.
  Combining three hobbies—travel, photography, and 
music—has proven to be delightful and fulfilling. He and 
his wife, June, have been to Italy, the Greek Islands, Russia, 
Estonia, Austria, Turkey, France, England, Ireland, Switzer-
land, and cruised the Danube. All of their journeys are pho-
tographically chronicled, with thousands of digital images 
set to music and hours of video stored on hard drives and 
Blu-ray discs, for his three children, eight grandchildren, 
and friends to enjoy.
 “The ability to enjoy life is a blessing,” said Dr. Gries. 
“A good education and a lot of perseverance are helpful in 
achieving this.”
 Luckily, Dr. Gries has both.
 





Sponsored by the American Associ-
ation of Bovine Practitioners (AABP), 
the Academy of Veterinary Consul-
tants (AVC), Bovine Veterinarian, 
Merck Animal Health, and Osborn 
Barr, an agricultural marketing 
and communications company, Dr. 
Woelffer has been nominated for the 
2013 Cattle Production Veterinar-
ian Hall of Fame which celebrates 
the rich traditions of production 
veterinary medicine by honoring 
exceptional individuals who have 
made lasting contributions to the 
veterinary profession. From the 
development of herd health proto-
cols and management strategies 
to maintaining leadership roles in 
teaching and research, these nomi-
nees have helped shape the indus-
try throughout their distinguished 
careers. Many consider Dr. Woelffer 
the father of bovine reproductive 
programs by integrating sound sci-
entific principles into reproductive 
programs. He was a member of the 
AVMA Executive Board and Profes-
sional Liability Trust. He received 
numerous awards, including the 
AABP Award for Excellence in 
Dairy Preventive Medicine and the 
Amstutz-Williams Award. He also 
was an honorary lifetime member 
of the AABP. Voting is currently 
underway and concludes August 5. 
AVC members may vote online at 
www.avc-beef.org/halloffame. AABP 
members may vote online at www.
aabp.org/halloffame.
Class of 1950
Dallas B. Tuthill DVM, MD
 Sun City Center, FL
Enjoyed chatting with Dean Kotlikoff 
and tour of the College of Veterinary 
Medicine in September 2012. Sorry 
to have missed Dr. Howie Evans, 
whom I knew when he first came 
to Cornell. Most if not all my class-
mates are gone, but some in suc-
ceeding classes might be interested. 
In any case, I am still around, and 
enjoying my Golden Years. Much 
nostalgia! Yay for veterinarians! 
Class of 1952
John H. Baldwin, DVM
 Greene, NY
I enjoy retirement with homes 
in Florida and Greene, NY. Keep 
in touch with Dr. Dann ’53, Dr. 
McVicar ’52, and Dr. NB Hayes ’52. 
Now out of the Harness Horses 
Business. I owned four (two very 
successful) with $100,000 earn-
ings! Still bowl and golf but not as 
well with “old age.” Enjoy info from 
Cornell. Also keep in touch with 
OTS info—our class of ’48 mem-
bers down to less than 20?
Class of 1960 
Adrian R. Morrison, DVM
 Rose Valley, PA
Dr. Adrian Morrison has published 
“Brandywine Boy,” his memoirs 
growing up in the Brandywine Val-
ley of southeastern Pennsylvania. 
Comprised of 11 chapters with illus-
trations by Gayle Joseph, an execu-
tive assistant at PennVet, the book 
chronicles in vivid detail Morrison’s 
adventures growing up in a postwar, 
changing rural environment. Though 
the writing project started out as a 
simple recording of stories for his 
family to enjoy, he now hopes others 
may be charmed by and learn from 
his tales. Morrison is self-publishing 
his book with assistance from Cre-
ateSpace. It is available on Amazon 
at http://tinyurl.com/brandywineboy
David Morrow III, DVM, PhD
 Deceased 2005
Sponsored by the American Associ-
ation of Bovine Practitioners (AABP), 
the Academy of Veterinary Consul-
tants (AVC), Bovine Veterinarian, 
Merck Animal Health, and Osborn 
Barr, an agricultural marketing and 
communications company, Dr. Mor-
row has been nominated for the 
2013 Cattle Production Veterinarian 
Hall of Fame which celebrates the 
rich traditions of production veteri-
nary medicine by honoring excep-
tional individuals who have made 
lasting contributions to the veteri-
nary profession. From the develop-
ment of herd health protocols and 
management strategies to main-
taining leadership roles in teaching 
and research, these nominees have 
helped shape the industry through-
out their distinguished careers. Dr. 
Morrow spent a lifetime committed 
to dairy cattle health and reproduc-
tive physiology, and earned numer-
ous accolades for his teaching and 
research at Michigan State Uni-
versity in the Department of Large 
Animal Surgery. Dr. Morrow was a 
charter member of the American 
College of Theriogenologists and is 
well-remembered for his textbook, 
“Current Therapy in Theriogenol-
ogy.” He was honored as the World 
Dairy Expo Industry Person of the 
Year in 1997. Voting is currently 
underway and concludes August 5. 
AVC members may vote online at 
www.avc-beef.org/halloffame. AABP 
members may vote online at www.
aabp.org/halloffame.
Class of 1978
George B. Nashe, DVM
 Woodbury, CT
Sherman Hill Animal Hospital, 431 
Sherman Hill Rd., Woodbury, CT, cel-
ebrated its fifth year under the own-
ership of Dr. George Nashe and his 
wife, Zheni Nashe. Dr. Nashe said 
he chose to be a veterinarian when 
he was already an adult, working as 
a restaurant manager in New York 
City and taking horseback riding 
lessons on weekends. “I watched a 
vet working at the barn where I was 
taking lessons and decided that’s 
what I wanted to do,” Dr. Nashe said 
he is exhilarated when he is part of 
a positive influence on an animal’s 
health. “But, turn it the other way; 
it’s a very sad occurrence when 
animals die. This job has its ups 
and downs. You don’t go into this 
profession thinking you’ll cuddle 
animals all the time and everything 
will be wonderful.” 
Class of 1985
Douglas L. Cohn, DVM
 Albany, NY
Cornell’s Johnson Museum of 
Art highlighted original paintings, 
drawings, and books for its recent 
exhibit “Beauties and the Beasties 
in Children’s Book Illustrations” 
(February 2 – May 5, 2013). Dr. 
Cohn, Director of the Animal 
Resources Facility, Albany Medical 
Center, provided from his collec-
tion a number of illustrations and 
original drafts used in well-known 




Natalie Gates has been selected as 
the new superintendent of Hale-
akala National Park on the island 
of Maui in Hawaii. Dr. Gates has 
worked at Point Reyes National 
Seashore in California for the last 
12 years, first as a wildlife biolo-
gist, and then as chief of natural 
resource management. She tran-
sitioned to her new duties at Hale-
akala in March. 
Class of 1994
Joseph A. Impellizeri III, DVM
 Hopewell Junction, NY
Dr. Joseph Impellizeri, a Diplomate 
of the American College of Veteri-
nary Internal Medicine (Oncology) 
recently returned from the Elec-
trochemotherapy 2nd International 
Users’ Meeting in Bologna, Italy. He 
presented data on the U.S. experi-
ence with Electrogenetherapy for 
telomerase immunotherapy in 
canine and feline patients. See 
http://www.vetcancertrials.org/
studies/vschv-telomerase-vaccine-
for-canine-cancer for more infor-
mation on this cancer vaccine. Dr. 
Impellizeri was the only veterinarian 
from the U.S. to be an invited pre-
senter among renowned physicians 




The LSU School of Veterinary 
Medicine’s Integrative Medicine 
Committee welcomed veterinarian 
Dr. Susan Ettinger to the Integra-
tive Medicine Program Speaker 
Series on Friday, April 19, 2013. 
Dr. Ettinger’s presentation was 
entitled, “Beyond Conventional Che-
motherapy.” Susan Ettinger, DVM, 
ACVIM (Oncology), is a staff medical 
oncologist with Animal Specialty 
Center in Yonkers, N.Y. In 2012, Dr. 
Ettinger was named one of the 60 
Top Veterinarians in Westchester, 
N.Y., and in 2011, she was named 
one of the Rising Stars 40 under 40 
by the Business Council of West-
chester. She is also co-author of the 
book, Dog Cancer Survival Guide, 
which was published in 2011.





Dr. Dana LeVine joins Iowa State’s 
Lloyd Veterinary Medical Center. Dr. 
LeVine studied molecular biochem-
istry at Yale University followed by 
a Doctor of Veterinary Medicine 
degree from Cornell University. She 
is an internist specializing in internal 
medicine. “I really like the com-
munity feel here,” LeVine said about 
Iowa State. LeVine discovered her 
passion for hematology, the study 
of blood, during veterinary school 
working alongside Dr. Marjory 
Brooks at Cornell University. “We 
were researching a platelet disorder 
in dogs, and Marjory definitely got 
me hooked,” Dr. LeVine said. Dr. 
Brooks continues to be a mentor 
and friend to Dr. LeVine. 
Class of 2008
Zenithson Ying Ng, DVM
 Blacksburg, VA
Dr. Zenithson Ng is the first vet-
erinarian to pursue a residency 
in human-animal bond studies in 
the United States, according to Dr. 
Bess Pierce, associate professor 
in the Department of Small Animal 
Clinical Sciences and director of the 
Virginia-Maryland Regional College 
of Veterinary Medicine’s Center for 
Animal Human Relationships. This 
innovative program is the only one 
of its kind at a veterinary college. 
A unique research, teaching, and 
service undertaking, the program is 
part of a growing body of research 
and outreach on the therapeutic 
benefits of companion animals. Dr. 
Ng has not yet decided what he 
will do after his residency, but he 
is certain that he will continue his 
life-long work on the human-animal 
bond, whether it be through leading 
veterinary care in private practice, 
shelter medicine, service animal 
organizations, or human-animal 
interaction programs.
We will include Class Notes in the February 2014 issue of ’Scopes Magazine. Please let us know what 
you’d like to share with your classmates in our Class Notes section by December 13, 2013, for inclusion.
SHARE YOUR NEWS
NAME     (MAIDEN IF APPROPRIATE)            CLASS YEAR
ADDRESS
EMAIL                   PHONE
Please tell my classmates that...
PLEASE RETURN TO: Cornell University, College of Veterinary Medicine, Box 39, Ithaca, NY 14853. Alternatively, share your 
information with us via email (vetfriends@cornell.edu) or complete the online form at www.vet.cornell.edu/alumni/ClassNotes.
IN MEMORIAM
SINCE THE LAST ISSUE OF 'SCOPES, THE COLLEGE HAS 
BEEN NOTIFIED OF THE PASSINGS OF THE FOLLOWING:
Dr. Elihu B. Boroson ’53, January 29, 2013
Dr. Daniel A. Cirnigliaro ’86, December 8, 2012
Dr. Richard E. Doran ’83, April 20, 2013
Dr. Stephen K. Ellis ’70, April 10, 2013
Dr. Richard E. Forrest ’61, April 6, 2013
Dr. John D. Goebel ’45, February 7, 2013
Dr. Boynton A. Grover ’43, December 8, 2012
Frederick LeBaron Hiltz PhD ’67, February 20, 2013
Kenneth Vincent Finlayson Jubb PhD ’55, February 27, 2013
Dr. Robert L. Kennedy ’55, January 28, 2013
Peter H. Langer, PhD ’60, October 25, 2012
Dr. Larry L. Larrow ’56, December 2, 2012
Dr. Arthur O. Lindblom Jr. ’53, March 14, 2013
Dr. Robert A. Mavian ’62, April 20, 2013
Dr. Anne Whiteford McComb ’83, January 18, 2013
Dr. John C. Meek ’55, April 14, 2013
Dr. James L. Meiczinger ’67, March 2, 2013
Dr. James R. O’Connor Jr. ’69, December 13, 2012
Dr. Albert P. Pontick ’39, July 24, 2012
Dr. Morris Leon Povar ’44, March 22, 2013
Dr. Robert P. Raemsch ’50, January 25, 2013
Dr. Harry E. Reddick, Jr. ’49, January 14, 2013
Dr. Robert J. Stack ’50, February 8, 2013
Dr. Edward George Trewick ’64, February 20, 2013
Dr. William C. Wagner ’56, December 10, 2012
In Dean Michael I. Kotlikoff’s address to the Class of 2013, he encouraged them to seize the moment: “This is your time. Your time to advance options and solutions to our shared challenges. Your time to challenge conventional wisdom. Your time to challenge yourselves and take informed risks. Your time to imagine and make discoveries and advances. It is your 

















wet labs   &   lectures
networking   &   exhibits
www.vet.cornell.edu/nysvc
